Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
25 February 2021 - 1:00AM
Syneos Health® (Nasdaq:SYNH), the only fully integrated
biopharmaceutical solutions organization, and Protocol First, Inc.,
a software solutions provider focused on accelerating clinical
research, today announced a novel strategic partnership aimed at
driving faster, more efficient clinical trials. The partnership is
expected to optimize data integration with Electronic Health Record
Systems and support Remote Source Data Review, further extending a
multi-year, pre-existing relationship between Syneos Health and
Protocol First.
The collaboration responds to the increasing demand
from biopharmaceutical customers for digital solutions that break
down silos between Sites, Sponsors, CROs and functional areas to
accelerate the collection and review of clinical trial research
data. The partnership further extends the expertise of Syneos
Health with Protocol First’s products by delivering advanced
knowledge transfer, product access, certification and other
competitive benefits. The partnership grants Syneos Health a
“First-to-Market” certification in terms of training and knowledge
transfer for configuration of the Protocol First software
products.
The enhanced collaboration furthers the ability of Syneos Health
to combine Protocol First’s proprietary software solutions that
integrate data from leading EHR systems into electronic data
capture (EDC) with operational insights from Syneos Health Dynamic
Assembly® network — an open ecosystem of best-of-breed data and
technology collaborators — to deliver fit-for-purpose customer
solutions. Combining these approaches allows the companies to
address customer nuances related to trial protocols, capturing and
analyzing clinical trial data faster and more efficiently with the
goal of accelerating product time-to-market. Syneos Health will use
Protocol First’s unique P1 Source Upload solution for remote
monitoring.
“This partnership with Protocol First further
strengthens our Dynamic Assembly network and supports our strategy
to bring creative solutions to research sites. By offering
cutting-edge, innovative technologies and critical insights, we are
working to help our clients bring medicines to market faster,” said
Paul Colvin, President, Clinical Solutions, for Syneos Health.
“Protocol First has been a leader in developing next-generation
technology solutions for complex clinical trials, and we’re pleased
that we could extend our partnership to improve patients’
lives.”
“Syneos Health, as a first mover participant in our
Protocol First Partnership, represents a milestone in the growth
and adoption of our innovative software solutions, including
Clinical Pipe and P1 Source Upload for remote monitoring. It is a
harbinger of the transformation of clinical research to a digital
model that ensures end-to-end data traceability in the most complex
‘precision medicine’ trials, while supporting remote and
decentralized study execution,” said Hugh P. Levaux, Ph.D., Founder
and CEO for Protocol First.
Building on the partnership and in response to the
COVID-19 pandemic, Syneos Health and Protocol First recently
developed and published a white paper to further demonstrate how a
proven technology solution can enable CRAs to perform their tasks
remotely. The white paper, Ensuring Data Quality During a Pandemic:
How Innovative Technology Supports Remote Source Document Review,
can be found here.
About Syneos HealthSyneos Health® (Nasdaq:SYNH)
is the only fully integrated biopharmaceutical solutions
organization. The Company, including a Contract Research
Organization (CRO) and Contract Commercial Organization (CCO), is
purpose-built to accelerate customer performance to address modern
market realities. We bring together approximately 25,000 clinical
and commercial minds with the ability to support customers in more
than 110 countries. Together we share insights, use the latest
technologies and apply advanced business practices to speed our
customers’ delivery of important therapies to patients. To learn
more about how we are Shortening the distance from lab to
life®, visit syneoshealth.com or subscribe to our
podcast.
About Protocol FirstProtocol
First, Inc., founded in 2015 and headquartered in Salt Lake
City, UT, develops next-generation technology solutions for complex
clinical trials in the Life Sciences industry. In addition to
its flagship Protocol First suite of cloud-based solutions
(eProtocol, Source Upload and EDC), Protocol First has launched
Clinical Pipe, the industry's first connector app that offers
system-agnostic EHR-to-EDC interoperability. The application
supports major EHR and EDC systems including Epic, Cerner,
Allscripts and Athena, as well as Medidata Rave, Oracle InForm, and
its own P1 platform. For additional information visit
www.protocolfirst.com.
Investor
Relations Contact: |
Press/Media
Contact: |
Ronnie Speight |
Gary Gatyas |
Senior Vice President, Investor Relations |
Executive Director, External Communications |
+1 919 745 2745 |
+1 908 763 3428 |
Investor.Relations@syneoshealth.com |
gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024